Related Experiment Video
Updated: Jun 29, 2025

06:46
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
261
Further Distance From Treating Facility is Associated With Advanced Colon Cancer at Presentation and Increased
Ryan K Schmocker1, Laura M Enomoto1, Gregory K Low2
1Division of Surgical Oncology, University of Tennessee Medical Center, Knoxville, TN, USA.
The American Surgeon
|March 29, 2024
Summary
Increased distance to treatment facilities is linked to advanced colon cancer stages and higher mortality rates, particularly affecting rural patients. This highlights disparities in cancer care access and the need for targeted interventions.
Area of Science:
- Oncology
- Public Health
- Health Services Research
Background:
- Colon cancer outcomes have improved in the US, but significant disparities persist, especially in rural areas.
- The independent impact of distance to treatment facilities on colon cancer mortality and outcomes remains unclear.
- This study investigates the relationship between facility distance, diagnosis stage, and mortality in colon cancer patients.
Purpose of the Study:
- To evaluate whether distance from a treating facility independently impacts colon cancer stage at diagnosis and mortality.
- To identify potential disparities in colon cancer care access related to geographic location.
Main Methods:
- Utilized the National Cancer Database (NCDB) for a cohort of adult colon cancer patients (2013-2017).
- Measured outcomes including colon cancer TNM stage, time to surgery, time to chemotherapy, and overall survival.
- Controlled for patient factors: race, education, insurance, comorbidities, and income.
Main Results:
- Increased distance to treating facilities significantly predicted more advanced clinical TNM stage at presentation (AORs 1.12-1.62, P < .001).
- Longer distances correlated with increased time to surgery (5.06-14.46 days, P < .001) and higher overall mortality (HR 1.11-1.28, P < .001).
- Median survival was significantly lower for patients living farther from treatment facilities (75.1 months vs. 82.4 months, P < .001).
Conclusions:
- Greater distance to treatment facilities is associated with higher colon cancer stage at diagnosis, delayed surgery, and increased mortality.
- Findings indicate significant disparities in cancer care access for rural populations.
- Targeted interventions are crucial for improving screening and timely treatment for rural colon cancer patients.
Related Concept Videos
Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345
Comparing the Survival Analysis of Two or More Groups
181
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
181
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K

